Literature DB >> 11791143

Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women.

C Sengenes1, V Stich, M Berlan, J Hejnova, M Lafontan, Z Pariskova, J Galitzky.   

Abstract

OBJECTIVE: We recently demonstrated that natriuretic peptides (NP) are involved in a pathway inducing lipolysis in human adipose tissue. Atrial NP (ANP) and brain NP (BNP) operate via a cGMP-dependent pathway which does not involve phosphodiesterase-3B inhibition or cAMP. The study was performed to evaluate the effect of ANP on lipid mobilization in obese women and secondly to examine the possible effect of a low-calorie diet (LCD) on the lipolytic response of subcutaneous abdominal fat cells to NP and on the lipid mobilization induced by ANP infusion (1 microg/m(2) min for 60 min).
SUBJECTS: Ten obese women from 40.5+/-3.4 y old were selected for this study. Their body weight was 96.4+/-5.7 kg and their BMI was 35.3+/-1.7 kg/m(2). They received a 2.5-2.9 MJ/day formula diet for 28 days.
DESIGN: Before and during the LCD, an adipose tissue biospy was performed for in vitro studies and, moreover, ANP was perfused i.v. to evaluate its lipid mobilizing action in toto and in situ in subcutaneous abdominal adipose tissue (SCAAT) using microdialysis.
RESULTS: The lipolytic effects of isoproterenol, ANP, BNP and bromo-cGMP (an analogue of cGMP) on fat cells increased by about 80-100% during LCD. The lipid mobilization during i.v. ANP infusion, assessed by plasma non-esterified fatty acids (NEFA) increase was enhanced during the LCD. However, during LCD, ANP infusion induced a biphasic effect on glycerol concentration in plasma and interstitial fluid of SCAAT; a significant increase was observed in glycerol levels during the first 30 min infusion period, followed by a steady decrease. The concentration of glycerol was lower during the post-infusion period than during the baseline period. This effect was stronger in obese subjects submitted to the LCD with a low-carbohydrate composition. Other plasma parameters were weakly increased (noradrenaline) or not modified (insulin, glucose) by ANP infusion and no difference was found before and during LCD treatment.
CONCLUSION: The present study shows that NP are powerful lipolytic agents in subcutaneous fat cells and that both isoproterenol- and NP-induced lipolysis increase during LCD, in obese women. These changes seem to be associated with an improvement of the lipolytic pathway at a post-receptor level. Moreover, i.v. administration of ANP induced a lipid mobilizing effect which was enhanced by a LCD in these objects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791143     DOI: 10.1038/sj.ijo.0801845

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  16 in total

Review 1.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

2.  Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.

Authors:  Andreas L Birkenfeld; Michael Boschmann; Cedric Moro; Frauke Adams; Karsten Heusser; Jens Tank; André Diedrich; Christoph Schroeder; Gabi Franke; Michel Berlan; Friedrich C Luft; Max Lafontan; Jens Jordan
Journal:  J Clin Endocrinol Metab       Date:  2006-09-19       Impact factor: 5.958

Review 3.  Management of cardiovascular diseases in patients with obesity.

Authors:  Carl J Lavie; Ross Arena; Martin A Alpert; Richard V Milani; Hector O Ventura
Journal:  Nat Rev Cardiol       Date:  2017-07-27       Impact factor: 32.419

4.  Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.

Authors:  Ian J Neeland; Benjamin R Winders; Colby R Ayers; Sandeep R Das; Alice Y Chang; Jarett D Berry; Amit Khera; Darren K McGuire; Gloria L Vega; James A de Lemos; Aslan T Turer
Journal:  J Am Coll Cardiol       Date:  2013-04-16       Impact factor: 24.094

Review 5.  B-type natriuretic peptide levels and benign adiposity in obese heart failure patients.

Authors:  Vasiliki Katsi; Maria Marketou; Alexios S Antonopoulos; Dimitrios Vrachatis; Fragkiskos Parthenakis; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

6.  Decrease in serum adiponectin levels in response to treatment predicts good prognosis in acute decompensated heart failure.

Authors:  Mika Matsumoto; Masaaki Lee-Kawabata; Takeshi Tsujino; Yoshiro Naito; Akira Ezumi; Tsuyoshi Sakoda; Mitsumasa Ohyanagi; Iichiro Shimomura; Tohru Masuyama
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08-20       Impact factor: 3.738

7.  Reactive oxygen species facilitate translocation of hormone sensitive lipase to the lipid droplet during lipolysis in human differentiated adipocytes.

Authors:  Sarah A Krawczyk; Jorge F Haller; Tom Ferrante; Raphael A Zoeller; Barbara E Corkey
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

8.  The heart as an endocrine organ.

Authors:  Tsuneo Ogawa; Adolfo J de Bold
Journal:  Endocr Connect       Date:  2014-04-15       Impact factor: 3.335

9.  N-terminal pro-B-type natriuretic Peptide in overweight and obese patients with and without diabetes: an analysis based on body mass index and left ventricular geometry.

Authors:  Seung Jei Park; Kyoung Im Cho; Sun Jae Jung; Sung Won Choi; Jae Won Choi; Dong Won Lee; Hyeon Gook Lee; Tae Ik Kim
Journal:  Korean Circ J       Date:  2009-12-30       Impact factor: 3.243

Review 10.  A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.

Authors:  Ryan P Ceddia; Sheila Collins
Journal:  Clin Sci (Lond)       Date:  2020-03-13       Impact factor: 6.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.